CD56-negative blastic natural killer-cell lymphoma (agranular CD4+/CD56+ haematodermic neoplasm)? [2]

British Journal of Dermatology

Volumn 152, Issue 2, 2005, Pages 369-370

  Kawai, K ^a  

^a NIIGATA UNIVERSITY GRADUATE SCHOOL OF MEDICAL AND DENTAL SCIENCES   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CD56 ANTIGEN;

AGED; CASE REPORT; CELL STRUCTURE; GENETIC HETEROGENEITY; HUMAN; IMMUNOHISTOCHEMISTRY; LETTER; LEUKEMIA; LYMPHOMA; MALE; NATURAL KILLER CELL; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; SKIN TUMOR;

AGED; ANTIGENS, CD56; HUMANS; KILLER CELLS, NATURAL; LYMPHOMA, T-CELL, CUTANEOUS; MALE; SKIN NEOPLASMS;

EID: 14844295401     PISSN: 00070963     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2133.2004.06296.x     Document Type: Letter

References (12)

1. Petrella T, Teitell MA, Spiekermann C et al. A CD56-negative case of blastic natural killer-cell lymphoma (agranular CD4+/CD56+ haematodermic neoplasm). Br J Dermatol 2004; 150:174-6.
2. Momoi A, Toba K, Kawai K A et al. Cutaneous lymphoblastic lymphoma of putative plasmacytoid dendritic cell-precursor origin: two cases. Leuk Res 2002; 26:693-8.
3. Chaperot L, Bendriss N, Manches O et al. Identification of a leukemic counterpart of the plasmacytoid dendritic cells. Blood 2001; 97:3210-17.
4. Petrella T, Comeau MR, Maynadie M et al. 'Agranular CD4+ CD56+ hematodermic neoplasm' (blastic NK-cell lymphoma) originates from a population of CD56+ precursor cells related to plasmacytoid monocytes. Am J Surg Pothol 2002; 26:852-62.
5. Feuillard J, Jacob MC, Valensi F et al. Clinical and biologic features of CD4+ CD56+ malignancies. Blood 2002; 99:1556-63.
6. Briere F, Bendriss-Vermare N, Delale T et al. Origin and filiation of human plasmacytoid dendritic cells. Hum Immunol 2002; 63:1081-93.
7. Jacob MC, Chaperot L, Mossuz P et al. CD4+ CD56+ lineage negative malignancies: a new entity developed from malignant early plasmacytoid dendritic cells. Haematologica 2003; 88:941-55.
8. Herling M, Teitell MA, Shen RR et al. TCL1 expression in plasmacytoid dendritic cells (DC2s) and the related CD4+ CD56+ blastic tumors of skin. Blood 2003; 101:5007-9.
9. Chaperot L, Perrot I, Jacob MC et al. Leukemic plasmacytoid dendritic cells share phenotypic and functional features with their normal counterparts. Eur J Immunol 2004; 34:418-26.
10. Shortman K, Liu YJ. Mouse and human dendritic cell subtypes. Nat Rev Immunol 2002; 2:151-61.
11. Chan JKC, Jaffe ES, Ralfkiaer E. Blastic NK-cell lymphoma. In: World Health Organization Classification of Tumours. Pathology and Genetics of Tumours of Haematopoietic and Lymphoid Tissues (Jaffe ES, Harris NL, Stein H, Vardiman JW, eds). Lyon: IARC Press, 2001; 214-15.
12. Petrella T, Dalac S, Maynadie M et al. CD4+ CD56+ cutaneous neoplasms: a distinct hematological entity? Groupe Français d'Étude des Lymphomes Cutanés (GFELC). Am J Surg Pathol 1999; 23:137-46.